60 Degrees Pharma
60 Degrees Pharmaceuticals develops and commercializes medicines for infectious diseases. Its work includes ARAKODA® for malaria prevention and research into treatments for other vector-borne and tick-borne diseases.
Visit WebsiteAbout 60 Degrees Pharma
60 Degrees Pharmaceuticals is a biotechnology and pharmaceutical company dedicated to developing and commercializing medicines for infectious diseases. Founded in 2010 and headquartered in Washington, DC, the company focuses on addressing unmet medical needs through scientific research, pharmaceutical development, and innovative treatment approaches.
The company’s portfolio includes ARAKODA®, a prescription medicine used for malaria prevention. In addition to its malaria-related work, 60 Degrees Pharmaceuticals is researching the potential of tafenoquine for other infectious diseases, including babesiosis and certain tick-borne illnesses.
Through clinical research, regulatory development, and collaboration with medical and scientific professionals, the company aims to expand treatment options for patients affected by infectious diseases. Its mission is to advance meaningful medical innovations that address unmet patient needs and improve healthcare outcomes.